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(Table). This association was stronger in women than in men (PzO.02 for interaction). 
Conclusion. Depression is associated with poorer functional benefits after CABG, partic- 
ularly in women. 
JACC March 19,2003 
Caucasians (CA, 31% females, p<O.OoOl) underwent 5560 PCls and 10384 CABG prc- 
cedures. Gender (p=O.l22) and race (p=O.641) had no significant impact on the choice of 
procedure. There were 397 (2.5% of 15994 patients) in-hospital post-procedural fatali- 
ties. Mortality rates were similar in AA and CA but significantly higher in women (3.3% 
versus 2.1% in men. p<O.OOOl). Within race analysis showed no effect of gender on mor- 
tality in all AA patients and in PCI or CABG groups separately. However, in-hospital mor- 
tality in CA women was 50% higher than in CA men (163/4865 versus 226/10700, 
p<O.OOOl). This mortality excess was observed only in CABG patients (4.2% in CA 
women versus 2.6% in CA men. p<O.OOOl). Detrimental effect of female gender on in- 
hospital mortality remained unchanged when outcomes were adjusted by age, diabetes, 
hypertension, congestive heart failure, and smoking history. 
Conclusion: In a large all-inclusive cohort of patients with coronary artery disease past- 
revascularization mortality was not affected by race. However, white women undergoing 
CABG incurred a 50% higher mortality than men. This gender-related increase in mortal- 
ity was independent of age, diabetes, and other co-morbidities. 
All Patients Man Women 
0 95% P for 0 95% P for 0 95% P for 
R Cl Trend R Cl Trend R Cl Trend 
No Depressfon 1 0.005 1 _ ~ 0.17 t- 0.006 
Mild Depression 1. 0.9. 1. 0.8. 1. 0.6 
4 2.3 5 2.9 3 3.0 
Definite 2. 1.3. 1. 0.6- 5. 1.6- 
Depression 7 5.5 6 4.2 6 17.4 
1144-56 Multivariate Analysis of 2,300 Patients Demonstrates 
Minimal Influence of Obesity on Outcomes for Coronary 
Bypass Surgery 
Louis I. Astra, Thomas E. Williams, Robert E. Michler. Ohio State University, Columbus, 
OH 
Background Obesity has been shown in multiple studies to result in additional risk 
of adverse outcomes in those undergoing coronary bypass surgery. In fact, obesity is 
used as an independent predictor of risk in several risk assessment scores including 
the Parsonnet and STS models. Our study examines the experience at Ohio State 
University to determine the effect of obesity on outcome. 
Methods: All patients that underwent isolated coronary bypass procedures, including 
reoperations, between January 1997 and June 2002 were examined retrospectively. 
A total of 2,334 procedures were performed. Of those, 296 patients were obese 
(BMI>=35, range 35.0-75.2, mean 40.2) and the remaining 2,026 patients acted as 
controls (BMlc35, range 16.3-34.9, mean 27.2). The obese group was compared to 
the controls with respect to age, gender, diabetes, history of myocardial infarction, 
and NYHA functional class. Survival and potential complications including sternal 
infections, pulmonary complications (pneumonia, ARDS. pulmonary embolus, 
prolonged ventilatory assistance), cerebrovascular events, and bleeding were then 
analyzed in a multivariate fashion. 
Results: (See Table)Of the preoperative variables, the only significant difference 
was gender, with the obese group having more females. No significant difference 
was found in perioperative mortality. There was also no difference in the frequency of 
reoperative surgery between groups. The only significant difference in morbidity was 
with superficial sternal wound infections, with the obese population having a higher 
risk. Of the remaining prelpostoperative variables, diabetes and postoperative 
bleeding approached statistical significance with obese patients more likely to be 
diabetic, and less likely to require blood transfusions. 
Conclusions Obesity is not an independent risk factor of survival in coronary 
bypass surgery. This study also demonstrates that obesity has minimal impact on 
outcomes, with the only effect being supedicial sternal infections. 
Patient and Outcome Analysis 
Variable Obase(BMI>=35) Controls (BMlr30) P value 
Male, % 53.0 72.0 <.OOOl 
Age (mean), Y 63.0 64.1 .6025 
Mortality, % 1.7 2.5 .4624 
Superficial Sternal, Infections, % 3.4 0.5 <.0001 
Deep Sternal Infections 0.7 0.5 .9355 
CVA (pertoperative), % 0.5 0.05 .6061 
Requiring blood transfusions, % 63.6 69.0 .0741 
1144-57 Outcomes in Coronary Revascularization Procedures: 
Race Is Less Important Than Gender 
Mikhail Torosoff, Robert D. Millar, Steven A. Fein, Jan L. Houghton, Edward F. Philbin. 
Ill, Albany Medical College, Albany, NY 
Background: Current literature suggests race and gender-related disparities in cardiovas- 
cular care delivery. Effects of gender and race on the outcomes of coronary revascular- 
ization procedures are debated. In addition, clinical outcomes of revascularization are 
potentially confounded by the selection bias when higher risk patients undergo lower risk 
procedures. To minimize this bias, we reviewed in-hospital outcomes in an all-inclusive 
cohort of patients undergoing any coronary revascularization procedures during the 
selected time period. 
Methods: All patients treated with coronary artery bypass grafting (CABG) or percutane- 
ous coronary intervention (PCI) at a tertiary medical center during 1997-2001 were 
included in the study. Contingency, ANOVA, and logistic regression analyses were 
employed to evaluate the determinants of in-hospital modality 
Results: During the study period, 379 African-Americans (AA, 44% females) and 15565 
1144-58 Intra- and Post-Operative Treatment end Course 
Variables Associated With Stroke Subtypes Following 
Coronary Artery Bypass Graft Surgery 
Donald S. Likosky, Steven P. Braff, Gregg S. Hartman, Eric S. Landis, Louis R. Caplan, 
Ronald M. Weintraub, Brett I. Applebaum, Cathy S. Ross, Gerald T. O’Connor, Northern 
New England Cardwascular Disease Study Group, Lebanon, NH 
Background: We previously determined that embolic and hypoperfusion strokes 
accounted for 62% and 9% of all strokes secondary to CABG surgery, respectively. In 
this study we quantified the association between intra- and post-operative factors and the 
risk of etiologic stroke subtypes. 
Methods We conducted a prospective cohort study of 26,009 patients undergoing iso- 
lated CABG surgery from 1992-2000. Etiology was classified as: embolic, hypoperfusion, 
or other. These analyses focused on the first two subgroups due to their homogeneity. 
Embolic strokes were defined as ischemic strokes with one of three likely sources of 
thrombus: aortic, cardiac or carotid. Hypoperfusion strokes were defined as strokes due 
to a mixture of extracranial stenoses and/or systemic hypotension. Odds ratios were 
adjusted for age, gender, diabetes, vascular disease, renal failure, acuity, ejection frac- 
tion. Those without strokes were the reference group for odds ratios. 
Results: Atrial fibrillation was significantly associated with embolic (OR 2.4, Cl ss-,- 1.6 - 
3.2, p<O.OOl) and hypoperfusion strokes (OR 5.4, Cl s5% 2.2 - 13.7, p<O.OOl). Patients 
having cardiopulmonary bypass duration greater than 120 minutes, versus less than 60 
minutes, had a 1.5-fold (Cl s5% 0.6 - 2.5, ptrend 0.03) risk of embolic, and a 6.4-fold 
(Cl ssx 0.8 - 52.0, ptrend 0.01) risk of hypoperfusion strokes. 
Conclusion: After adjusting for preoperative factors, post-operative atrial fibrillation and 
duration of cardiopulmonary bypass remained significant predictors of both embolic and 
hypopelfusion strokes. Prevention and management of atrial fibrillation and attention to 
prolonged exposure to extracorporeal circulation may offer leverage areas for the 
improvement of stroke outcomes. 
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1169-51 People at Increased Risk of Cardiovascular Disease 
Screened for the NAVIGATOR Trial Frequently Have 
Undiagnosed Diabetes or Impaired Glucose Tolerance 
Robelt M. Califf, Rury Holman, on behalf of the Navigator Trial Steering Committee and 
Investigators, Duke Clinical Research Institute, Raleigh, NC, Oxford Centre for Diabetes, 
Endocrinology and Metabolism, Oxford, United Kingdom 
Background: Impaired glucose tolerance (IGT) and type 2 diabetes (T2DM) increase the 
risk of cardiovascular disease (CVD) 2-4 fold. NAVIGATOR (Nateglinide and Valsartan in 
IGT Outcomes Research) is a multinational, randomized, placebo-controlled, double- 
blind, 2x2 factorial design trial investigating whether progression to T2DM or new CVD 
events can be reduced by nateglinide and/or valsartan. 7500 individuals SO y with CVD 
or ~555 v with risk factors for CVD and with IGT are beina recruited. Results: Of the 7215 
people screened by August 2002, man and women were equally represented, most were 
Caucasian 181%) with mean f*lSD) bodv mass index 30+6 kc/m* and 1546 have been 
I  ,  _  
randomised. The prevalence of impaired fasting glucose (IFG), IGT and TPDM did not 
differ between those with risk factors for CVD and those who had already had a CVD 
event. Only a minority had normal glucose tolerance (NGT): 
255~ + risk factors 
~50~ + CVD 
” Age NGT IFG IGT DM 
4946 64i6 30.4% 11.6% 30.7% 27.2% 
1963 63+8 31 .O% 12.3% 28.9% 27.6% 
Conclusion: These results suggest that, in people at increased risk for CVD, diabetes is 
frequently undiagnosed and that IGT is common. Oral glucose tolerance testing should 
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be considered in individuals with CVD risk factors or established CVD to identify and 
treat those with diabetes. The results of the NAVIGATOR trial will indicate whether treat- 
ment of those with IGT can reduce their CVD risk. 
1169-52 Low Socioeconomic Status Is More Predictive of 
Increased Hazard in Women Than Men After 
Angiographic Diagnosis of Coronary Artery Disease 
Sandra P. Revna Joseph B. Muhlestem, Benjamin D. Home, Tami L. Bair, Chloe A. 
Allen Maycock, Robert R. Pearson, Stephanie V. Moore, Dale G. Renlund, Jeffrey L. 
Anderson, LDS Hospital, Salt Lake City, UT, University of Utah, Salt Lake City, UT 
Background: Low socioeconomic status (SES) has been associated with an increased 
risk of coronary heart disease. We previously demonstrated that a geographic-based sur- 
rogate measure of SES, residential economic status @ES), predicts the risk of coronary 
events among patients with CAD. However, the impact of SES might differ by gender. 
Methods: Between 1993 and 1999, a cohort of 7,147 patients (men [n=5,310]. average 
age: 64+11 years; women [n=l,837], average age: 68i12 years) with advanced, angle- 
graphically-defined CAD (>70% stenosis) was evaluated for RES and outcome by gen- 
der. RES was determined by the median household income (1990 US Census) of each 
patient’s residential zip code. Twenty-two demographic variables, cardiac risk factors, 
clinical variables, and treatment therapies were also recorded at baseline. Proportional 
hazards regression was used to examine the risk of incident CAD events, defined as 
death and nonfatal myocardial infarction (Ml), over an average follow-up of 3.4e2.0 yrs 
(maximum, 7.3 years). 
Results: Overall event rates were 33.2% for wcmen and 27.6% for men (p<O.OOl). A 
significant inverse association was observed between quintiles of RES and incident CAD 
for both women (32.8%, 32.9%, 30.8%. 22.9% 24.3%; P-trend=O.OOl) and me” (25.3%, 
24.3% 23.6%, 22.2%, 20.2%; P-trend<O.OOl). but the effect of low RES was amplified in 
wmen with an apparent threshold. Low RES was associated with an adjusted relative 
hazard (RH) of incident death/Ml of 1.47 (95% Cl=1.23-1.75) in women versus 1.14 (95% 
CI=l.OZ-1.27) in men, comparmg RES quintiles 1-3 with quintiles 4-5. The interaction 
between gender and RES on death/Ml was significant (adjusted p-value for interaction = 
O.O4S).Conclusion: Lower RES predicts incident coronary events rn women as well as 
men with CAD. Indeed, low RES was found to pose a greater hazard in women. Further 
studies, which include precise measures of SES, are now indicated to define the gender- 
related and other factors causing these poor wtcOmes in subjects with low SES. 
1169-53 Effect of Ethnicity on Long-Term Outcomes Following 
Percutaneous Coronary intervention in a Setting With 
Universal Access to Health Care 
Linda L. Huffer, Robert E. Eckart, Eric A. Shry. Jose A. DeHoyos, Daniel E. Simpson, 
Brooke Army Medical Center, Fort Sam Houston, TX 
Background: We sought to examine the role of ethnicity in those undergoing percutane- 
ous coronary intervention (PCI) in a health care system in which there is universal 
access. Methods: We retrospectwely rewewed all percutaneous interventions performed 
on Caucasians, African Americans. or HIspanics from 1 Jan1 998 to 1 lAug2001 at Brooke 
Army Medical Center. Data in a centralwed database included patient co-morbidities, 
angiography and intervention findings, and post-PC1 pharmacologic interventions. One 
year following the procedure, subjects were reassessed for death, need for surgical or 
percutaneous revascularizatlon, and biochemical evidence of myocardial mjury. Results: 
There were 933 mterventlons performed on 888 subjects (Caucasian n=719,African- 
Amertcan w77,Hrspanic n=92) wer the specified time period. The mean age of African 
Americans was lower than Caucasians (60.3+10 3 vs 64.5+11 .1,95% Cl 1.6-6.8) with a 
similar mcidence of diabetes (33.8%~~ 27.7%.p=O.32) and an equivalent ejection fraction 
(52.7~14.1~~52.5~13.1, p=O.91). Compared to Caucasians, African Americans were 
more likely to undergo revascularization withln one-year (24.7%vsl4.2%,p=O.O2) and die 
(14.5%vs6.6%,p=O.O2). When controlled for age, ejectron fraction, presentation for acute 
myocardlal infarctlon, and hrstory of diabetes, African-American race was a statistically 
significant risk factor for death (OR 3.97, 95% Cl 1.50-10.54). When stent implantation 
was added to the multivariate analysis for death, African-American race remained a sig- 
nificant predictor (OR 4.28.95% Cl 1.56-11.73). Compared to Caucasians, Hispanics 
showed no differences in revascularization. myocardial injury, or death. Conclusions: 
Although there were procedural differences noted I” subjects of differing ethnicity. this 
did not explain the increased mortality I” African Americans in a system with equal 
access to care. 
1169-54 Value of Routine Holter Screening for the Detection of 
Paroxysmal Atrial Fibrillation in Patients With Cerebral 
lschemic Attacks 
Beat A. Schaer. Thomas A. Cron, Stefan Oswald, University Hospital, Basel. 
Switzerland 
Background: Halter-monrtoring for the detectjon of paroxysmal atrial fibrillation (PAF) in 
addition to echocardiography and carotic Doppler is a routine procedure after cerebral 
ischemic attacks (CIA), although the reported incidence of PAF is low and the value of 
Halter with this indication unknown. Aim of this study was to evaluate the incidence of 
PAF, to assess the Impact of Its diagnosis on drug regimen mcdiflcation (DRM) and to 
calculate the cost-effectiveness of Halter as a screenmg test. 
Methods: All bolters and ethos (lTETTEE) of pts with CIA, referred to our clinic for the 
evaluation of a possible thromboembolic source, were analyzed by two cardiologists. 
PAF was defined as at least 20 consecutive arrhythmlc ventricular beats (RR-interval 
irregularity .25%). 
Results: Between OllOO and 06102, 308 pts (age 35 to 92y, median 68) had a routine 24 
hour-Halter after CIA (17% of all Halters). PAF was diagnosed in 9 pts (3%): in 2 pts 
anticoagulation (AC) was refused or contraindicated: 2 pts were on AC and PAF was 
already documented on a lzlead-ECG; 1 pt had a carotic stenosis > 90% as an addi- 
tional risk factor for CIA; 1 pt had PAF, but was on AC for a basilar thrombosis; 1 had 
PAF before and therefore was on ASS; in 2 pts, a new diagnosis of PAF was established. 
The last 3 pts were put on AC after Halter, resulting in 3/308 (1%) DRM. Given the costs 
of 150 $ per Halter. there were overall expenses of 46’200 $. that is 5’130 $ per PAF or 
15’400 5 per DRM. The “number-needed-to-investigate” was 102 Halters for one DRM. 
In 270 pts, echocardtography was performed (144 TTE, 76 TEE, 50 TTWEE). In 86 
(32%) pts a potential swrce of emboksm was detected (slgndicant plaques 55%, for- 
mane wale 36%, other 9%). Conclusions: Our data demonstrate that PAF in CIA- 
patients: 1) has a low incidence 2) if diagnosed, hardly leads to a drug modification 3) 
has high per-case-costs. Therefore, routine Halter screening is not recommended in pts 
with CIA. On the other hand, echocardlography has a much higher yield to detect possi- 
ble abnormalities responsible for a CIA. 
1169-55 Effect of Green Tea Intake on the Development of 
Coronary Artery Disease 
Junk0 Sane, Tomohiro Ogawa, Shigenobu Inami, Fumiyuki Ishibashi. Kentaro 
Okamatsu, Hiroyuki Kamon, Kouji Selmiya, Gen Takagi, Shunta Sakai, Atsunobu 
Nomura. Kyoichl Mizuno, Chiba Hokusoh Hospital, Nippon Medical School, Chlba, Japan 
Background Japanese have a low incidence of coronary artery diseases (CAD), 
although plasma cholesterol levels and the incidence of diabetes mellltus are not differ- 
ent between Japan and Western counties and the frequency of smoking is high in Japan. 
The daily intake of food and green tea, which contains many polyphenolic antioxidants, 
are considered to be the low incidence of CAD. To determine the influence of diet on 
CAD, we analyzed the relationship between the dietary habits and the incidence of CAD. 
Methods This study comprised 309 patients (pts) who underwent coronary angiography 
(180 pts with CAD and 129 pts without CAD). Coronary risk factors, serum Itpids, daily 
intake of green tea and red wine, vitamin supplementation (C and E) and dietary habits 
(vegetable, fruits, soy beans and fish), were assessed The predictors for CAD were ana- 
lyzed by multlvariate logtstic regression analysis. 
Results The daily intake of green tea (cups/day) was significantly higher in pabents 
without CAD than in those with CAD (5.6k3.9 vs. 3.1t4.0; p=O.OOO). Independent predic- 
tors based on multlvariate analysis were green tea, vegetable, male, age, diabetes melli- 
tus (DM), hyperlipidemia (HL), and smoking. 
Conclusions The more green tea patients intake, the lesser CAD occur. Ingestion of 
green tea and vegetable are responsible, in part, for the low incidence of CAD in the Jap- 
anese population despite high incidence of cigarette smoktng. Tea consumption may be 
much useful than vegetable to prevent coronary artery disease. 
Tsa Vegetable Male Age DM HL Smokin 
g 
(per cup/ (per time/ 
day) day) 
Odds 0.85 0.73 3.25 1.07 2.14 2.47 1.97 
Ratio 
98% Cl 0.78-0.93 0.57-O 94 1.64- 1.04. 1.10. 1.41. 1.09. 
6.41 1.10 4.16 4.31 3.56 
P 0.0002 0.0129 0.0007 0.0000 0 0248 0.0015 0.0246 
1169-56 Gender Differences in Survival After Admission for 
Acutely Decompensated Heart Failure 
Doron Aronsoq Darlene P. Horton, Andrew J. Burger, Rambam Medical Center, Haifa, 
Israel. Beth Israel Deaconess Medical Center, Boston, MA 
Introduction: Natural history studies on patients with congestive heart failure have sug- 
gested that the prognosis of women is better than that for men. However, it IS not known 
whether female surwval advantage extends to patients with severe decompensated 
heart failure. 
Methods: We studied 560 patients (mean age 63 * 14 years, 377 male) with a previous 
diagnosis of heart failure (96% with New York Heart Association functional class III or IV) 
who were admitted to hospital for decompensated heart failure. 
Results: During a mean follow-up of 343 f 185 days, 177 patients (32%) died. Kaplan- 
Meieranalys~s indicated that female patients were at a lower risk of death (Figure). A Cox 
proportional-hazards model, adjusted for age, weight, diabetes status, primary etiology of 
heart failure stratified as ischemic or nonischemic. serum sodium, serum creatinine and 
medications (ACE Inhibitors, P-blockers, digoxin, or amiodarone), showed a significant 
association between female gender and better survival following hospital discharge (RR 
= 0.66, 95% Cl 0.46-0.96, p = 0.029). Predictors of increased mortality after hospital dis- 
charge included serum sodium < 135 mmollL (RR = 1.9, 95% Cl 1.4-2.6, p = O.OOOl), 
and ischemic heart failure (RR = 1.7, 95% Cl 1.2-2.3, p = 0.002). 
